VUITY (nda214028)- (1.25%)

Generic Name	PILOCARPINE HYDROCHLORIDE	Innovator	ABBVIE
Dosage	1.25%
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2039-Apr-24	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2024-Oct-28
GAIN Expiry	None	Drug Complexity	No
Indication	VUITY is a cholinergic muscarinic receptor agonist indicated for the treatment of presbyopia in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	8

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
1.25%	**	**	Down	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of VUITY